Publicaciones en las que colabora con Jan K. Buitelaar (8)

2023

  1. The future of child and adolescent clinical psychopharmacology: A systematic review of phase 2, 3, or 4 randomized controlled trials of pharmacologic agents without regulatory approval or for unapproved indications

    Neuroscience and Biobehavioral Reviews, Vol. 149

2022

  1. The transition from adolescence to adulthood in patients with schizophrenia: Challenges, opportunities and recommendations

    European Neuropsychopharmacology, Vol. 59, pp. 45-55

  2. Virtual Ontogeny of Cortical Growth Preceding Mental Illness

    Biological Psychiatry, Vol. 92, Núm. 4, pp. 299-313

2021

  1. A white paper on a neurodevelopmental framework for drug discovery in autism and other neurodevelopmental disorders

    European Neuropsychopharmacology, Vol. 48, pp. 49-88

  2. Author Correction: Altered structural brain asymmetry in autism spectrum disorder in a study of 54 datasets (Nature Communications, (2019), 10, 1, (4958), 10.1038/s41467-019-13005-8)

    Nature Communications

2019

  1. Altered structural brain asymmetry in autism spectrum disorder in a study of 54 datasets

    Nature Communications, Vol. 10, Núm. 1

2018

  1. Cortical and subcortical brain morphometry differences between patients with autism spectrum disorder and healthy individuals across the lifespan: Results from the ENIGMA ASD working group

    American Journal of Psychiatry, Vol. 175, Núm. 4, pp. 359-369

2015

  1. Unmet needs in paediatric psychopharmacology: Present scenario and future perspectives

    European Neuropsychopharmacology, Vol. 25, Núm. 10, pp. 1513-1531